- Home
- IMNM vs CNOBP Comparison
IMNM vs CNOBP Comparison
Compare IMNM & CNOBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- CNOBP
- Stock Information
- Founded
- IMNM 2006
- CNOBP N/A
- Country
- IMNM United States
- CNOBP United States
- Employees
- IMNM N/A
- CNOBP 493
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- CNOBP Major Banks
- Sector
- IMNM Health Care
- CNOBP Finance
- Exchange
- IMNM Nasdaq
- CNOBP Nasdaq
- Market Cap
- IMNM 748.3M
- CNOBP N/A
- IPO Year
- IMNM 2020
- CNOBP N/A
- Fundamental
- Price
- IMNM $8.77
- CNOBP $23.09
- Analyst Decision
- IMNM Strong Buy
- CNOBP
- Analyst Count
- IMNM 5
- CNOBP 0
- Target Price
- IMNM $26.40
- CNOBP N/A
- AVG Volume (30 Days)
- IMNM 1.1M
- CNOBP N/A
- Earning Date
- IMNM 08-11-2025
- CNOBP N/A
- Dividend Yield
- IMNM N/A
- CNOBP N/A
- EPS Growth
- IMNM N/A
- CNOBP N/A
- EPS
- IMNM N/A
- CNOBP N/A
- Revenue
- IMNM $10,938,000.00
- CNOBP N/A
- Revenue This Year
- IMNM N/A
- CNOBP N/A
- Revenue Next Year
- IMNM $310.65
- CNOBP N/A
- P/E Ratio
- IMNM N/A
- CNOBP N/A
- Revenue Growth
- IMNM N/A
- CNOBP N/A
- 52 Week Low
- IMNM $5.15
- CNOBP N/A
- 52 Week High
- IMNM $16.81
- CNOBP N/A
- Technical
- Relative Strength Index (RSI)
- IMNM 49.38
- CNOBP 57.87
- Support Level
- IMNM $8.60
- CNOBP $22.86
- Resistance Level
- IMNM $9.27
- CNOBP $23.08
- Average True Range (ATR)
- IMNM 0.46
- CNOBP 0.12
- MACD
- IMNM -0.03
- CNOBP 0.00
- Stochastic Oscillator
- IMNM 44.57
- CNOBP 87.76
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.